Enhanced disease resistance conferred by expression of an antimicrobial magainin analog in transgenic tobacco

Q Li1, C B Lawrence, H Y Xing

  • 1THRI, University of Kentucky, Lexington 40546-0236, USA. agr022@pop.uky.edu

Planta
|August 30, 2001
PubMed

Insights

Engineered magainin analog Myp30 enhances plant resistance to oomycete and bacterial pathogens. Transgenic tobacco expressing Myp30 showed reduced disease symptoms, demonstrating its potential in crop protection.

Area of Science:

  • Agricultural Science
  • Molecular Biology
  • Plant Pathology

Background:

  • Magainins are antimicrobial peptides from frog skin, acting as a natural defense.
  • Engineered magainin analog Myp30 exhibits antimicrobial properties in vitro.
  • Plant diseases caused by oomycetes and bacteria pose significant threats to agriculture.

Purpose of the Study:

  • To evaluate the efficacy of transgenic tobacco plants expressing Myp30 against oomycete and bacterial pathogens.
  • To assess the impact of Myp30 expression location on plant resistance.

Main Methods:

  • Development of transgenic tobacco (Nicotiana tabacum L.) plants expressing the Myp30 peptide.
  • In vitro testing of Myp30 against Peronospora tabacina and Erwinia carotovora subsp. carotovora.
  • Evaluation of disease resistance in transgenic plants under pathogen challenge.

Main Results:

  • Myp30 expression significantly reduced sporulation and lesion size caused by P. tabacina.
  • Transgenic plants showed increased resistance to Erwinia carotovora subsp. carotovora, irrespective of Myp30 localization.
  • Extracellular expression of Myp30 was particularly effective against P. tabacina.

Conclusions:

  • The engineered magainin analog Myp30 confers resistance to key plant pathogens in transgenic tobacco.
  • Myp30 holds potential as a novel tool for developing disease-resistant crops.
  • Targeted expression of antimicrobial peptides can be an effective strategy for crop protection.